University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review


- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is a cancer care center. It offers cancer treatment, cancer research, education, and research-based prevention of both common and rare cancers in adult and pediatric patients. The company's major departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers graduate, undergraduate, and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; among others. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

Jun 20,2024: CAR NK Cells with CD28 Costimulation Improved Cell Persistence and Antitumor Activity
Jun 05,2024: New Clinical Research Provides Evidence that Proton Therapy Offers Significant Patient Benefits for Head and Neck Cancer Treatment
Jun 04,2024: ASCO: Proton Therapy Demonstrates Advantages in Phase III Head and Neck Cancer Trial
Jun 01,2024: ASCO: Novel Targeted Cancer Therapies Demonstrate Activity and Safety in Metastatic Solid Tumors

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company
University of Texas MD Anderson Cancer Center - Key Facts
University of Texas MD Anderson Cancer Center - Key Employees
University of Texas MD Anderson Cancer Center - Key Employee Biographies
University of Texas MD Anderson Cancer Center - Major Products and Services
University of Texas MD Anderson Cancer Center - History
University of Texas MD Anderson Cancer Center - Company Statement
University of Texas MD Anderson Cancer Center - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
University of Texas MD Anderson Cancer Center - Business Description
Business Segment: Auxiliary Income
Performance
Business Segment: Grants and Contracts
Performance
Business Segment: Net Patient Revenue
Performance
Business Segment: Net Sales and Services of Educational Activities
Performance
Business Segment: Other Income
Performance
R&D Overview
University of Texas MD Anderson Cancer Center - Corporate Strategy
University of Texas MD Anderson Cancer Center - SWOT Analysis
SWOT Analysis - Overview
University of Texas MD Anderson Cancer Center - Strengths
University of Texas MD Anderson Cancer Center - Weaknesses
University of Texas MD Anderson Cancer Center - Opportunities
University of Texas MD Anderson Cancer Center - Threats
University of Texas MD Anderson Cancer Center - Key Competitors
University of Texas MD Anderson Cancer Center, Recent Deals Summary
Section 3 – Company’s Recent Developments
Jun 20, 2024: CAR NK Cells with CD28 Costimulation Improved Cell Persistence and Antitumor Activity
Jun 05, 2024: New Clinical Research Provides Evidence that Proton Therapy Offers Significant Patient Benefits for Head and Neck Cancer Treatment
Jun 04, 2024: ASCO: Proton Therapy Demonstrates Advantages in Phase III Head and Neck Cancer Trial
Jun 01, 2024: ASCO: Novel Targeted Cancer Therapies Demonstrate Activity and Safety in Metastatic Solid Tumors
May 31, 2024: ASCO: Novel CAR TTherapy and Shorter Targeted Therapy Durations Show Promise for Patients With Leukemia
May 23, 2024: MD Anderson Research Highlights: ASCO 2024 Special Edition
May 21, 2024: MD Anderson Research Highlights for May 21, 2024
May 16, 2024: End-of-Life Systemic Treatment for Patients with Advanced Cancers Does Not Improve Survival
May 08, 2024: MD Anderson Research Highlights for May 8, 2024
May 01, 2024: MD Anderson and Pan American Health Organization Join Forces to Support Cancer Prevention and Control in the Americas
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
University of Texas MD Anderson Cancer Center, Key Facts
University of Texas MD Anderson Cancer Center, Key Employees
University of Texas MD Anderson Cancer Center, Key Employee Biographies
University of Texas MD Anderson Cancer Center, Major Products and Services
University of Texas MD Anderson Cancer Center, History
University of Texas MD Anderson Cancer Center, Subsidiaries
University of Texas MD Anderson Cancer Center, Joint Venture
University of Texas MD Anderson Cancer Center, Key Competitors
University of Texas MD Anderson Cancer Center, Recent Deals Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings